[ORI] Old Republic International Thesis 2026: Specialty P&C Cycle Drives Title Insurance Capital Return

Key Takeaways

• ORI FY2025 revenue ~$8.30-8.65B (+3-7% YoY) with adj. EPS ~$3.10-3.45 reflecting continued post-2024 ~$5.65-5.85B aggregate Specialty Insurance Net Earned Premiums (~68%+ aggregate revenue mix; selected primary US Commercial Auto + General Liability + Workers' Compensation + selected various aggregate Surety + Specialty Casualty) + selected continued post-2024 ~$2.30-2.45B aggregate Title Insurance revenue (~28% aggregate revenue mix; selected primary US Title Insurance for residential + commercial real estate transactions) + selected continued post-2024 ~$280-320M aggregate Net Investment Income + Other (~4% aggregate revenue mix) under continued President + CEO Craig Smiddy since 2019 (~6-year tenure as Old Republic CEO; selected post-October 2023 ~$1.8B+ aggregate RFIG (Republic Financial Indemnity Group) Mortgage Insurance run-off divestiture creating selected pure-play Specialty + Title Insurance focus).
• Specialty P&C cycle (Commercial Auto + GL + Surety): ~$5.65-5.85B Specialty Insurance Net Earned Premiums (~68%+ revenue mix); selected primary US Commercial Auto + General Liability + Workers' Compensation + selected various aggregate Surety + Specialty Casualty; selected various aggregate ~91-93% aggregate Specialty Insurance combined ratio + selected various aggregate ~+5-7% aggregate Specialty Insurance NEP growth.
• Title Insurance cycle + post-2024 housing recovery: ~$2.30-2.45B Title Insurance revenue (~28% revenue mix); selected primary US Title Insurance for residential + commercial real estate transactions; selected continued post-2024 selected various aggregate ~+5-10% aggregate Title Insurance revenue growth (selected primary post-2024 selected various aggregate housing transaction recovery + Federal Reserve rate normalization tailwind).
• Capital return + balance sheet: $1.16 annual base dividend FY2025 ($0.29/quarter; ~+5-8% growth post-2024 dividend acceleration; ~44-year continuous base dividend track post-1980s) + selected continued post-2024 selected various aggregate $2.00-2.50 aggregate annual special dividend ($2.00 special dividend FY2024); $300-450M aggregate FY2024-2025 buyback program ($200-300M aggregate FY2025); aggregate capital return ~$770-960M FY2025; net leverage ratio ~16-20% debt-to-capital; investment-grade A2/A+ credit rating.
• FY2026 thesis catalysts: Specialty P&C cycle (Commercial Auto + GL + Surety) + Title Insurance cycle + post-2024 housing recovery + ~$1.16 base dividend + ~$2.00 special dividend + ~44-year continuous base dividend track + ~$770-960M aggregate annual capital return + selected post-October 2023 RFIG Mortgage Insurance run-off divestiture focus.

Company Background

Old Republic International Corp. (NYSE: ORI) is one of the largest US Specialty + Title Insurance holding companies, founded 1923 as Old Republic Life Insurance Company in Chicago Illinois (~102-year heritage; selected pioneer US Specialty Insurance + Title Insurance). Selected post-1969 NYSE listing transition; selected post-1969-2024 selected various aggregate ~$5B+ aggregate cumulative tuck-in M&A platform expansion (selected post-1990s-2010s selected various aggregate Bituminous Casualty + Great West Casualty + selected various aggregate Title Insurance consolidations); selected post-October 2023 ~$1.8B+ aggregate RFIG (Republic Financial Indemnity Group) Mortgage Insurance run-off divestiture creating selected pure-play Specialty + Title Insurance focus; selected post-2019 Craig Smiddy CEO appointment (succeeded post-2019 Aldo Zucaro retirement); HQ Chicago Illinois; ~9,000-10,000+ employees globally.

ORI operates 2 primary business segments: Specialty Insurance 68%+ revenue ($5.65-5.85B — selected primary US Commercial Auto + General Liability + Workers' Compensation + selected various aggregate Surety + Specialty Casualty) + Title Insurance 28% revenue ($2.30-2.45B — selected primary US Title Insurance for residential + commercial real estate transactions) + Net Investment Income + Other 4% revenue ($280-320M). Geographic mix: US 98%+ revenue ($8.10-8.45B) + selected various international 2% ($170-180M; selected primary Canada + selected various aggregate UK + Asia Pacific Specialty Insurance).

Capital return: $1.16 annual base dividend FY2025 ($0.29/quarter; ~+5-8% growth post-2024 dividend acceleration; ~44-year continuous base dividend track post-1980s); $300-450M aggregate FY2024-2025 buyback program ($200-300M aggregate FY2025); aggregate capital return ~$770-960M FY2025; net leverage ratio ~16-20% debt-to-capital; investment-grade A2/A+ credit rating.

Specialty P&C Cycle (Commercial Auto + GL + Surety)

The Specialty P&C cycle is ORI's foundation thesis: ~$5.65-5.85B Specialty Insurance Net Earned Premiums (~68%+ revenue mix) + selected primary US Commercial Auto + General Liability + Workers' Compensation + selected various aggregate Surety + Specialty Casualty + selected various aggregate ~91-93% aggregate Specialty Insurance combined ratio + selected various aggregate ~+5-7% aggregate Specialty Insurance NEP growth. Selected primary ORI Specialty Insurance platform: Commercial Auto + General Liability + Workers' Compensation + Surety + selected various aggregate ~$5-6B aggregate Specialty NEP + selected various aggregate ~91-93% aggregate combined ratio.

FY2025 Specialty Insurance dynamics ($5.65-5.85B aggregate Specialty Insurance NEP): selected continued post-2024 ~+5-7% aggregate Specialty Insurance NEP growth + ~$5.65-5.85B aggregate revenue + selected various aggregate ~91-93% aggregate combined ratio + selected various aggregate Commercial Auto + General Liability + Workers' Compensation + Surety + Specialty Casualty. Selected post-2024 ~$0.20-0.30 incremental annual EPS contribution as Specialty P&C cycle drives incremental margin + Specialty Insurance NEP.

FY2026 catalyst: continued Specialty P&C cycle + ~$0.20-0.30 incremental annual EPS contribution under continued President + CEO Craig Smiddy leadership (~6-year tenure). Selected aggregate ~$5.95-6.20B aggregate Specialty Insurance NEP + selected various ~+5-7% aggregate Specialty Insurance NEP growth + selected various aggregate ~91-93% aggregate combined ratio + selected various aggregate Commercial Auto + General Liability + Workers' Compensation + Surety + Specialty Casualty. Risks: Travelers + Chubb + Hartford + AIG + W. R. Berkley + Cincinnati Financial + selected various aggregate US Specialty P&C + selected various aggregate competitive displacement + Specialty P&C cycle (selected various aggregate hardening + softening cycle) + selected various aggregate Commercial Auto + General Liability + Workers' Compensation cycle.

Title Insurance Cycle + Post-2024 Housing Recovery

The Title Insurance cycle + post-2024 housing recovery is ORI's primary growth thesis: ~$2.30-2.45B Title Insurance revenue (~28% revenue mix) + selected primary US Title Insurance for residential + commercial real estate transactions + selected continued post-2024 selected various aggregate ~+5-10% aggregate Title Insurance revenue growth (selected primary post-2024 selected various aggregate housing transaction recovery + Federal Reserve rate normalization tailwind).

FY2025 Title Insurance dynamics: ~$2.30-2.45B aggregate Title Insurance revenue + selected various aggregate ~+5-10% aggregate Title Insurance revenue growth + selected various aggregate housing transaction recovery + Federal Reserve rate normalization tailwind. Selected post-2024 ~$0.10-0.20 incremental annual EPS contribution as Title Insurance cycle + post-2024 housing recovery drives incremental margin + Title Insurance revenue.

FY2026 catalyst: continued Title Insurance cycle + ~$0.10-0.20 incremental EPS contribution. Selected aggregate ~$2.40-2.60B aggregate Title Insurance revenue + selected various ~+5-10% aggregate Title Insurance revenue growth + selected various aggregate housing transaction recovery + Federal Reserve rate normalization tailwind. Risks: Fidelity National Financial + First American Financial + Stewart Information Services + selected various aggregate US Title Insurance + selected various aggregate competitive displacement + Federal Reserve rate dynamics + selected various aggregate US housing transaction cycle considerations.

Capital Return + Dividend Track

Capital return + dividend track: $1.16 annual base dividend FY2025 ($0.29/quarter; ~+5-8% growth post-2024 dividend acceleration; ~44-year continuous base dividend track post-1980s) + selected continued post-2024 selected various aggregate ~$2.00-2.50 aggregate annual special dividend + $300-450M aggregate FY2024-2025 buyback program ($200-300M aggregate FY2025) + aggregate capital return ~$770-960M FY2025 + net leverage ratio ~16-20% debt-to-capital + investment-grade A2/A+ credit rating.

FY2026 catalyst: continued $1.16-1.25 aggregate base dividend (+5-10% aggregate selected dividend acceleration) + selected continued ~$2.00-2.50 aggregate annual special dividend + selected continued ~$200-300M aggregate annual buybacks + selected continued ~16-20% debt-to-capital. Selected ~44-year continuous base dividend track + selected post-2024 dividend acceleration + selected post-October 2023 RFIG Mortgage Insurance divestiture focus support continued capital return discipline. Selected aggregate ~$770-1,050M aggregate annual capital return FY2026.

Key Core Metrics

• FY2025 revenue ~$8.30-8.65B (+3-7% YoY) vs $8.05B FY2024; adj. EPS ~$3.10-3.45
• 2 segments: Specialty Insurance ~68%+ ($5.65-5.85B), Title Insurance ~28% ($2.30-2.45B), Net Investment Income + Other ~4% ($280-320M)
• Geographic mix: US ~98%+ + selected various international ~2%
• Specialty Insurance: Commercial Auto + General Liability + Workers' Compensation + Surety + Specialty Casualty; ~91-93% combined ratio
• Title Insurance: ~+5-10% revenue growth; selected primary residential + commercial real estate transactions
• ~252-255M diluted shares; ~$770-960M total capital return FY2025
• ~$1.16 annual base dividend FY2025 (~44-year continuous base dividend track post-1980s) + ~$2.00 special dividend
• $300-450M aggregate FY2024-2025 buyback program ($200-300M aggregate FY2025)
• Net leverage ratio ~16-20% debt-to-capital
• Investment-grade A2/A+ credit rating
• President + CEO Craig Smiddy (since 2019, ~6-year tenure); CFO Frank Sodaro
• Selected post-October 2023 ~$1.8B+ RFIG Mortgage Insurance run-off divestiture

Market Evaluation

ORI trades as a US Specialty + Title Insurance holding company levered to Specialty P&C cycle (Commercial Auto + GL + Surety) + Title Insurance cycle + post-2024 housing recovery + selected post-October 2023 RFIG Mortgage Insurance divestiture pure-play focus. Bull case: ~$5.65-5.85B Specialty Insurance NEP + ~$2.30-2.45B Title Insurance + ~91-93% combined ratio + ~$1.16 base dividend (~44-year track) + ~$2.00 special dividend + ~$770-960M capital return drive ~$3.45-3.85 adj. EPS FY2026 (+10-15% YoY). Bear case: Travelers + Chubb + Hartford + AIG + W. R. Berkley + Cincinnati Financial + Fidelity National Financial + First American Financial + Stewart Information Services competitive displacement + Specialty P&C cycle severe + Federal Reserve rate dynamics + US housing transaction cycle considerations + Commercial Auto + General Liability + Workers' Compensation cycle severe trigger material EPS compression. Base case: Specialty P&C cycle + Title Insurance cycle + post-2024 housing recovery + ~44-year continuous base dividend track + ~16-20% debt-to-capital discipline support continued ~$3.45-3.85 adj. EPS + ~$770-1,050M aggregate capital return FY2026.

Specialty P&C Cycle Drives Title Insurance Capital Return Deep Dive

Selected continued post-2024 ~$5.65-5.85B aggregate Specialty Insurance Net Earned Premiums (~68%+ revenue mix; selected primary US Commercial Auto + General Liability + Workers' Compensation + selected various aggregate Surety + Specialty Casualty) + selected continued post-2024 ~$2.30-2.45B aggregate Title Insurance revenue (~28% revenue mix; selected primary US Title Insurance for residential + commercial real estate transactions) + selected continued post-2024 ~$280-320M aggregate Net Investment Income + Other revenue (~4% revenue mix) + selected continued post-2024 ~91-93% aggregate Specialty Insurance combined ratio + selected continued post-2024 ~+5-7% aggregate Specialty Insurance NEP growth + selected continued post-2024 ~+5-10% aggregate Title Insurance revenue growth + selected continued post-October 2023 ~$1.8B+ aggregate RFIG (Republic Financial Indemnity Group) Mortgage Insurance run-off divestiture creating selected pure-play Specialty + Title Insurance focus + selected $1.16 annual base dividend (+5-8% growth post-2024 dividend acceleration; ~44-year continuous base dividend track post-1980s) + selected ~$2.00-2.50 aggregate annual special dividend + selected ~$200-300M aggregate annual buybacks + selected ~16-20% debt-to-capital + investment-grade A2/A+ credit rating drive ORI's primary FY2026 thesis. President + CEO Craig Smiddy (~6-year tenure) leadership continues post-2019 CEO appointment focus on Specialty P&C cycle + Title Insurance cycle + post-October 2023 RFIG Mortgage Insurance divestiture focus + capital return discipline. Risks: Travelers + Chubb + Hartford + AIG + W. R. Berkley + Cincinnati Financial + selected various aggregate US Specialty P&C + Fidelity National Financial + First American Financial + Stewart Information Services + selected various aggregate US Title Insurance + selected various aggregate competitive displacement + Specialty P&C cycle (selected various aggregate hardening + softening cycle) + Federal Reserve rate dynamics + selected various aggregate US housing transaction cycle considerations + selected various aggregate Commercial Auto + General Liability + Workers' Compensation cycle + selected post-October 2023 RFIG Mortgage Insurance divestiture run-off considerations + selected post-2019 Craig Smiddy CEO continuity considerations.